收藏切换
Exploration of the efficacy and mechanism of dapagliflozin on heart failure with preserved ejection fraction
收藏切换
Weihua PENG1, Xiaoke SHANG2, Changdong ZHANG2, Shu'na XIAO3
World Clinical Drug | 2025, 46(11) : 1156 - 1162
Less
收藏切换
World Clinical Drug | 2025, 46(11): 1156-1162
• Article •
Exploration of the efficacy and mechanism of dapagliflozin on heart failure with preserved ejection fraction
Full
Weihua PENG1, Xiaoke SHANG2, Changdong ZHANG2, Shu'na XIAO3
Affiliations
  • 1.Department of Cardiovascular Medicine, Fugou Huimin Hospital of Traditional Chinese Medicine, Zhoukou 466000, Henan Province, China
  • 2.Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, Hubei Province, China
  • 3.Department of Cardiovascular Medicine, Wuhan Ninth Hospital, Wuhan 430000, Hubei Province, China
Published: 2025-11-10 doi: 10.13683/j.wph.2025.11.011
Outline
收藏切换
Objective

To explore the efficacy and mechanism of sodium-glucose cotransporter (SGLT)-2 inhibitor dapagliflozin in the treatment of patients with heart failure with preserved ejection fraction (HFpEF).

Methods

HFpEF patients admitted to Fugou Huimin Hospital of Traditional Chinese Medicine from January 2023 to December 2024 were selected as the subjects and divided into the observation group and the control group, with 50 cases in each group.The control group was treated with conventional therapy, while the observation group was treated with dapagliflozin in combination. The changes of echocardiographic indicators, inflammatory factors, cardiac function indicators and myocardial fibrosis indicators in the two groups were compared, and the incidences of adverse reactions and major cardiovascular event (MACE) were also compared.

Results

After treatment, the left ventricular end-diastolic diameter, left ventricular end-systolic diameter, peak velocity of early mitral valve blood flow/peak velocity of early mitral valve annulus in the observation group were all lower than those in the control group, and the left ventricular ejection fraction was higher, with significant differences (P<0.05). The levels of high-sensitivity C-reactive protein, interleukin-6, N-terminal pro-brain natriuretic peptide, creatine kinase, creatine kinase isoenzyme, α -hydroxybutyrate dehydrogenase, soluble growth-stimulating expression gene 2 protein, connective tissue growth factor, and matrix metalloproteinase-9 in the observation group were all lower than those in the control group, and the differences were all significant (P<0.05).After a 3-month follow-up, the incidence of MACE in the observation group was lower than that in the control group (P<0.05).

Conclusion

Dapagliflozin has a significant short-term therapeutic effect on patients with HFpEF, which can reduce the inflammatory response of the body, improve cardiac function and myocardial fibrosis, and lower the incidence of short-term MACE. Moreover, it has good safety.

sodium-glucose cotransporter 2  /  heart failure with preserved ejection fraction  /  dapagliflozin  /  inflammatory factor  /  myocardial fibrosis
彭伟华, 尚小珂, 张长东, 肖书娜. 达格列净对射血分数保留型心力衰竭的疗效及机制探讨. 世界临床药物, 2025 , 46 (11) : 1156 -1162 . DOI: 10.13683/j.wph.2025.11.011
Weihua PENG, Xiaoke SHANG, Changdong ZHANG, Shu'na XIAO. Exploration of the efficacy and mechanism of dapagliflozin on heart failure with preserved ejection fraction[J]. World Clinical Drug, 2025 , 46 (11) : 1156 -1162 . DOI: 10.13683/j.wph.2025.11.011
Year 2025 volume 46 Issue 11
44
10
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.11.011
  • Receive Date:2025-05-11
  • Online Date:2026-11-09
  • Published:2025-11-10
Article Data
Affiliations
History
  • Received:2025-05-11
  • Revised:2025-09-12
Affiliations
    1.Department of Cardiovascular Medicine, Fugou Huimin Hospital of Traditional Chinese Medicine, Zhoukou 466000, Henan Province, China
    2.Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, Hubei Province, China
    3.Department of Cardiovascular Medicine, Wuhan Ninth Hospital, Wuhan 430000, Hubei Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.11.011
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT